Cytokine regulation of HIV replication induced by dendritic cell-CD4-positive T cell interactions

AIDS Research and Human Retroviruses

Volumn 12, Issue 9, 1996, Pages 759-767

  Weissman, Drew ^a   Daucher, James ^a   Barker, Tobias ^a,b   Adelsberger, Joseph ^c   Baseler, Michael ^c   Fauci, Anthony S ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4;

ANTIGEN PRESENTING CELL; ARTICLE; CELL INTERACTION; DENDRITIC CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE RESPONSE; INFECTION; LYMPHOID TISSUE; MIXED LYMPHOCYTE REACTION; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VIREMIA; VIRUS REPLICATION;

B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CELL COMMUNICATION; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOKINES; DENDRITIC CELLS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HIV-1; HUMANS; INTERFERON TYPE II; INTERLEUKINS; LYMPHOCYTE ACTIVATION; TUMOR NECROSIS FACTOR-ALPHA; VIRUS REPLICATION;

EID: 0029897365     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1996.12.759     Document Type: Article

References (71)

1. Poli G and Fauci AS: The role of cytokines in the pathogenesis of HIV disease. In: Human Cytokines: Their Role in Health and Human Disease (Aggarwal BB and Puri RK, eds.). Blackwell Scientific Publications, Cambridge, Massachusetts, 1995, pp. 421-449.
2. Poli G and Fauci AS: Cytokine modulation of HIV expression. Semin Immunol 1993;5:165-173.
3. Clerici M, Hakim FT, Venzon DJ, Blatt S, Hendrix CW, Wynn TA, and Shearer GM: Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus seropositive individuals. J Clin Invest 1993;91:759-765.
4. Maggi E, Mazzetti M, Ravina A, Annunziato F, de Carli M, Piccinni MP, Manetti R, Carbonari M, Pesce AM, del Prete G, and Romagnani S: Ability of HIV to promote a TH1 to TH0 shift and to replicate preferentially in TH2 and TH0 cells. Science 1994;265:244-248.
5. Graziosi C, Pantaleo G, Gantt KR, Fortin JP, Demarest JF, Cohen OJ, Sékaly RP, and Fauci AS: Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIV-infected individuals. Science 1994;265:248-252.
6. Embretson J, Zupancic M, Ribas JL, Burke A, Racz P, Tenner-Racz K, and Haase AT: Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature (London) 1993;362:359-362.
7. Pantaleo G, Graziosi C, Demarest JF, Butini L, Montroni M, Fox CH, Orenstein JM, Kotler DP, and Fauci AS: HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature (London) 1993;362:355-358.
8. Armstrong JA and Home R: Follicular dendritic cells and virus-like particles in AIDS-related lymphadenopathy. Lancet 1984;ii(8399):370-372.
9. Tenner-Racz K, Racz P, Dietrich M, and Kem P: Altered follicular dendritic cells and virus-like particles in AIDS and AIDS-related lymphadenopathy. Lancet 1985;i(8420):105-106.
10. Racz P, Tenner-Racz K, Kahl C, Feller AC, Kern P, and Dietrich M: The spectrum of morphologic changes of lymph nodes from patients with AIDS or AIDS-related complexes. Progr Allergy 1986;37:81-181.
11. Biberfeld P, Chayt KJ, Marselle LM, Biberfeld G, Gallo RC, and Harper ME: HTLV-III expression in infected lymph nodes and relevance to pathogenesis of lymphadenopathy. Am J Pathol 1986;125:436-442.
12. Le Tourneau A, Audouin J, Diebold J, Marche C, Tricottet V, and Reynes M: LAV-like particles in lymph node germinal centers in patients with the persistent lymphadenopathy syndrome and the acquired immunodeficiency syndrome-related complex: An ultrastructural study of 30 cases. Hum Pathol 1986;17:1047-1053.
13. Cohen OJ, Pantaleo G, Holodniy M, Schnittman S, Niu M, Graziosi C, Pavlakis GN, Lalezari J, Bartlett JA, Stiegbigel RT, Cohn J, Novak R, McMahon D, and Fauci AS: Decreased HFV-1 plasma viremia during antiretroviral therapy reflects downregulation of viral replication in lymphoid tissue. Proc Natl Acad Sci USA 1995;92:6017-6021.
14. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, and Markowitz M: Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature (London) 1995;373: 123-126.
15. Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P, Lifson JD, Bonhoeffer S, Nowak MA, Hahn BH, Saag MS, and Shaw GM: Viral dynamics in human immunodeficiency virus type 1 infection. Nature (London) 1995;373:117-122.
16. Cheynier R, Henrichwark S, Hadida F, Pelletier E, Oksenhendler B, Autran B, and Wain-Hobson S: HIV and T cell expansion in splenic white pulps is accompanied by infiltration of HIV-specific cytotoxic T lymphocytes. Cell 1994;78:373-387.
17. Steinman RM: The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991;9:271-296.
18. Romani N and Schuler G: The immunologic properties of epidermal Langerhans cells as a part of the dendritic cell system. Springer Semin Immunopathol 1992;13:265-279.
19. Ibrahim MA, Chain BM, and Katz DR: The injured cell: The role of the dendritic cell system as a sentinel receptor pathway. Immunol Today 1995;16:181-186.
20. Weissman D, Li Y, Orenstein JM, and Fauci AS: Both a precursor and a mature population of dendritic cells can bind HIV; however, only the mature population that expresses CD80 can pass infection to unstimulated CD4 positive T cells. J Immunol 1995;155:4111-4117.
21. Donaldson YK, Bell JE, Ironside JW, Brettle RP, Robertson JR, Busuttil A, and Simmonds P: Redistribution of HIV outside the lymphoid system with onset of AIDS. Lancet 1994;343:383-385.
22. Weissman D, Li Y, Ananworanich J, Zhou L-J, Adelsberger J, Tedder TF, Baseler M, and Fauci AS: Three populations of cells with dendritic morphology exist in peripheral blood, only one of which is infectable with human immunodeficiency virus type 1. Proc Natl Acad Sci USA 1995;92:826-830.
23. Linsley PS, Greene JL, Brady W, Bajorath J, Ledbetter JA, and Peach R: Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity 1994;1:793-801.
24. Lanier LL, O'Fallon S, Somoza C, Phillips JH, Linsley PS, Okumura K, Ito D, and Azuma M: CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL. J Immunol 1995;154: 97-105.
25. Caux C, Vanbervliet B, Massacrier C, Azuma M, Okumura K, Lanier L, and Banchereau J: B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells. J Exp Med 1994;180:1841-1847.
26. Trinchieri G, Kubin M, Bellone G, and Cassatella MA: Cytokine cross-talk between phagocytic cells and lymphocytes: Relevance for differentiation/activation of phagocytic cells and regulation of adaptive immunity. AIDS Res Hum Retroviruses 1993;53: 301-308.
27. Kobayashi M, Fitz L, Ryan M, Hewick RM, Clark SC, Chan S, Loudon R, Sherman F, Perussia B, and Trinchieri G: Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med 1989;170:827-845.
28. Trinchieri G, Wysocka M, D'Andrea A, Rengaraju M, Aste-Amezaga M, Kubin M, Valiante NM, and Chehimi J: Natural killer cell stimulatory factor (NKSF) or interleukin-12 is a key regulator of immune response and inflammation. Progr Growth Factor Res 1992;4:355-368.
29. Markowicz S and Engleman EG: Granulocyte-macrophage colony-stimulating factor promotes differentiation and survival of human peripheral blood dendritic cells in vitro. J Clin Invest 1990; 85:955-961.
30. Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, and Mosmann TR: Interleukin-10. Annu Rev Immunol 1993;11: 165-190.
31. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, and de Vries JE: Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174:1209-1220.
32. + T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. J Immunol 1993;150:4754-4765.
33. Ellis J, Ibrahim MA, Chain BM, and Katz DR: The role of dendritic cells in the regulation of T cell cytokine synthesis. Adv Exp Med Biol 1993;329:99-104.
34. van Wilsem E, Breve J, van Hoogstraten I, Savelkoul H, and Kraal G: The influence of dendritic cells on T-cell cytokine production. Adv Exp Med Biol 1993;329:111-115.
35. Folks TM, Kelly J, Benn S, Kinter A, Justement J, Gold J, Redfield R, Sell KW, and Fauci AS: Susceptibility of normal human lymphocytes to infection with HTLV III/LAV. J Immunol 1986; 136:4049-4953.
36. McDougal JS, Mawle A, Cort SP, Nicholson JKA, Cross GD, Scheppler-Cambell JA, Hicks D, and Sligh J: Cellular tropism of the human retrovims HTLV-III/LAV I: Role of T cell activation and expression of the T4 antigen. J Immunol 1985;135:3151-3162.
37. Spina CA, Kwoh TJ, Chowers MY, Guatelli JC, and Richman DD: The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes. J Exp Med 1994;179:115-123.
38. Zack JA, Arrigo SJ, Weitsman SR, Go AS, Haislip A, and Chen IS: HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals labile, latent viral structure. Cell 1990;61:213-222.
39. Zack JA, Haislip AM, Krogstad P, and Chen IS: Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle. J Virol 1992;66:1717-1725.
40. Miller MD, Warmerdam MT, Gaston I, Greene WC, and Feinberg MB: The human immunodeficiency virus-1 nef gene product: A positive factor for viral infection and replication in primary lymphocytes and macrophages. J Exp Med 1994;179:101-113.
41. Bukrinsky MI, Stanwick TL, Dempsey MP, and Stevenson M: Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. Science 1991;254:423-427.
42. Zagury D, Bernard J, Leonard R, Cheynier R, Feldman M, Sarin PS, and Gallo RC: Long-term cultures of HTLV-III-infected T cells: A model of cytopathology of T-cell depletion in AIDS. Science 1986;231:850-853.
43. - T cells in acute HIV infection in vitro. J Immunol 1993;150:5202-5208.
44. Kinter AL, Poli G, Fox L, Hardy E, and Fauci AS: HIV replication in IL-2-stimulated peripheral blood mononuclear cells is driven in an autocrine/paracrine manner by endogenous cytokines. J Immunol 1995;154:2448-2459.
45. Kazazi F, Mathijs JM, Chang J, Malafiej P, Lopez A, Dowton D, Sorrell TC, Vadas MA, and Cunningham AL: Recombinant interleukin 4 stimulates human immunodeficiency virus production by infected monocytes and macrophages. J Gen Virol 1992;73: 941-949.
46. Novak RM, Holzer TJ, Kennedy MM, Heynen CA, and Dawson G: The effect of interleukin 4 (BSF-1) on infection of peripheral blood monocyte-derived macrophages with HIV-1. AIDS Res Hum Retroviruses 1990;6:973-976.
47. Schuitemaker H, Kootstra NA, Koppelman MH, Bruisten SM, Huisman HG, Tersmette M, and Miedema F: Proliferation-dependent HIV-1 infection of monocytes occurs during differentiation into macrophages. J Clin Invest 1992;89:1154-1160.
48. Chehimi J, Starr SE, Frank I, D'Andrea A, Ma X, MacGregor RR, Sennelier J, and Trinchieri G: Impaired interleukin 12 production in human immunodeficiency virus-infected patients. J Exp Med 1994;179:1361-1366.
49. Biswas P, Poli G, Kinter AL, Justement JS, Stanley SK, Maury WJ, Bressler P, Orenstein JM, and Fauci AS: Interferon gamma induces the expression of human immunodeficiency virus in persistently infected promonocytic cells (U1) and redirects the production of virions to intracytoplasmic vacuoles in phorbol myristate acetate-differentiated U1 cells. J Exp Med 1992;176:739-750.
50. 2 stimulatory cytokines interleukin-12 and interleukin-4 on human immunodeficiency virus replication. Blood 1995; 85:2114-2123.
51. Schuler G, Brang D, Cameron P, and Romani N: Production and properties of large numbers of dendritic cells from human blood. Abstract presented at the Keystone Symposium, Dendritic Cells: Antigen Presenting Cells of T and B Lymphocytes, Taos, NM, March 10-16, 1995.
52. + T cells. J Immunol 1995;154:5071-5079.
53. Kootstra NA, van't Wout A, Huisman HG, Miedema F, and Schuitemaker H: Interference of interleukin-10 with human immunodeficiency virus type 1 replication in primary monocyte-derived macrophages. J Virol 1994;68:6967-6975.
54. Montaner LJ, Griffin P, and Gordon S: Interleukin-10 inhibits initial reverse transcription of human immunodeficiency virus type 1 and mediates a virostatic latent state in primary blood-derived human macrophages in vitro. J Gen Virol 1994; 75:3393-3400.
55. Akridge RE, Oyafuso LK, and Reed SG: IL-10 is induced during HIV-1 infection and is capable of decreasing viral replication in human macrophages. J Immunol 1994;153:5782-5789.
56. Saville MW, Taga K, Foli A, Broder S, Tosato G, and Yarchoan R: Interleukin-10 suppresses human immunodeficiency virus-1 replication in vitro in cells of the monocyte/macrophage lineage. Blood 1994;83:3591-3599.
57. Weissman D, Poli G, and Fauci AS: Interleukin 10 blocks HIV replication in macrophages by inhibiting the autocrine loop of tumor necrosis factor alpha and interleukin 6 induction of virus. AIDS Res Hum Retroviruses 1994;10:1199-1206.
58. Mitra RS, Judge TA, Nestle FO, Turka LA, and Nickoloff BJ: Psoriatric skin-derived dendritic cell function is inhibited by exogenous IL-10. Differential modulation of B7-1 (CD80) and B7-2 (CD86) expression. J Immunol 1995;154:2668-2677.
59. Barcellini W, Rizzardi GP, Borghi MO, Fain C, Lazzarin A, and Meroni A: TH1 and TH2 cytokine production by peripheral blood mononuclear cells from HIV-infected patients. AIDS 1994; 8:757-762.
60. Fan J, Bass HZ, and Fahey JL: Elevated IFN-gamma and decreased IL-2 gene expression are associated with HIV infection. J Immunol 1993;151:5031-5040.
61. McGowan I, Radford-Smith G, and Jewell DP: Cytokine gene expression in HIV-infected intestinal mucosa. AIDS 1994;8: 1569-1575.
62. Navikas V, Link J, Wahren B, Persson C, and Link H: Increased levels of interferon-gamma (IFN-gamma), IL-4 and transforming growth factor-beta (TGF-beta) mRNA expressing blood mononuclear cells in human HIV infection. Clin Exp Immunol 1994;96: 59-63.
63. Cayota A, Vuillier F, Scott-Algara D, Feuillie V, and Dighiero G: Impaired proliferative capacity and abnormal cytokine profile of naive and memory CD4 T cells from HIV-seropositive patients. Clin Exp Immunol 1992;88:478-483.
64. + T-cell clones in human immunodeficiency virus infection. Blood 1994;84: 4262-4268.
65. Boyle MJ, Berger MF, Tschuchnigg M, Valentine JE, Kennedy BG, Divjak M, Cooper DA, Turner JJ, Penny R, and Sewell WA: Increased expression of interferon-gamma in hyperplastic lymph nodes from HIV-infected patients. Clin Exp Immunol 1993;92:100-105.
66. Emilie D, Peuchmaur M, Maillot MC, Crevon MC, Brousse N, Delfraissy JF, Dormont J, and Galanaud P: Production of interleukins in human immunodeficiency virus-1-replicating lymph nodes. J Clin Invest 1990;86:148-159.
67. Steffen M, Reinecker HC, Petersen J, Doehn C, Pfluger I, Voss A, and Raedler AL: Differences in cytokine secretion by intestinal mononuclear cells, peripheral blood monocytes and alveolar macrophages from HIV-infected patients. Clin Exp Immunol 1993;91:30-36.
68. Kovacs JA, Baseler M, Dewar RJ, Vogel S, Davey RT Jr, Falloon J, Polis MA, Walker RE, Stevens R, Salzman NP, Metcalf JA, Maser H, and Lane HC: Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary study. N Engl J Med 1995;332:567-575.
69. + cell anti-HIV activity: Nonlytic suppression of virus replication. AIDS Res Hum Retroviruses 1992;8:1039-1050.
70. + cell clones derived from HIV-infected and uninfected individuals. Cell Immunol 1994; 159:271-279.
71. + T cells and this effect overrides its ability to stimulate virus expression. Proc Natl Acad Sci USA 1995; 92:10985-10989.